Почетна › Занимања › Regulatory Affairs Managers › Gaithersburg, MD
Regulatory Affairs Managers u Gaithersburg, MD: H-1B plate
20 prijava za uslove rada za ovo zanimanje sa radnim mestom u Gaithersburg, MD. Medijana ponuđene osnovne plate $164.800; srednja polovina $143.750–$184.732.
По нивоу плата
| Ниво зараде | Медијална плата |
|---|---|
| Ниво I (почетни) | $128.750 |
| Ниво II (квалификовани) | $138.682 |
| Ниво III (искусни) | $173.802 |
| Ниво IV (потпуно компетентни) | $195.000 |
Ministarstvo rada određuje četiri nivoa važeće plate za svako zanimanje i oblast, od Nivoa I (početni) do Nivoa IV (potpuno kompetentan). Poslodavac bira nivo koji odgovara zahtevima posla.
Послодавци
| Послодавац | LCA | Медијална плата |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $178.104 |
| Novavax, Inc. | 7 | $160.000 |
| Alexion Pharmaceuticals, Inc. | 2 | $208.284 |
| Emergent Product Development Gaithersburg Inc. | 1 | $140.000 |
| Salubris Biotherapeutics Inc. | 1 | $128.750 |
| Horizon Therapeutics USA, Inc. | 1 | $167.200 |
Назив позиције
- Associate Director,Safety Surveillance Global Vaccine Safety4
- Associate Regulatory Affairs Director3
- Senior Manager, QPPV Office, Global Vaccine Safety2
- Manager, Regulatory Affairs CMC1
- Director, Quality Science and Processes1
- Manager, Regulatory Affairs1
- Manager Corporate Strategy and Clinical Development1
- Sr. Manager, CMC Regulatory Affairs (Rare Disease)1
- Associate Director, Regulatory Science & Execution1
- Director, Labeling1
- Associate Regulatory Affair Director1
- Associate Director, Patient Safety Scientist1
- Regulatory Affairs Portfolio Director1
- Global Regulatory Affairs Director1
H-1B sponzori u Gaithersburg, MD →
Plate su donja graneta ponuđene zarade po svakoj prijavi, preračunata na godišnji nivo; statistika koristi samo sertifikovane prijave za puno radno vreme. LCA nije odobrenje vize i jedna LCA može pokrivati više pozicija. Izvor: Američki ministarstvo rada, OFLC LCA podaci o otkrivanju, fiskalne godine 2023–2026 (najnovija odluka 30. 6. 2026.).